Levophacetoperane

From Wikipedia, the free encyclopedia

Jump to: navigation, search
Levophacetoperane
Phacetoperane chemical structure.png
Systematic (IUPAC) name
[(R)-phenyl-[(2R)-piperidin-2-yl]methyl] acetate
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • ℞ (Prescription only)
Identifiers
CAS Number 24558-01-8 YesY
ATC code none
PubChem CID 15706387
ChemSpider 32702188
UNII 3SZ9ZII529
Chemical data
Formula C14H19NO2
Molar mass 233.31 g/mol
  (verify)

Levophacetoperane (Lidépran, Phacétoperane) is a psychostimulant developed by Rhône-Poulenc in the 1950s.[1] The drug has been used as an antidepressant and anorectic.[2][3] It is the reverse ester of methylphenidate.

See also[edit]

References[edit]

  1. ^ Joseph Nicole Marie; Jacob Robert Michel (15 March 1960). "Patent US 2928835 - New esters". Rhône-Poulenc. 
  2. ^ Delbeke, F. T.; Debackere, M. (26 March 1975). "Isolation and detection of methylphenidate, phacetoperane and some other sympatomimetic central nervous stimulants with special reference to doping". Journal of Chromatography A. 106 (2): 412–417. doi:10.1016/S0021-9673(00)93853-6. PMID 239015 – via ScienceDirect. 
  3. ^ Eric Konofal; Bruno Figadere (5 February 2015). "Patent Application US 20150038533 - Phacetoperane for the treatment of attention-deficit hyperactivity disorder". Assistance Publique – Hôpitaux de Paris.